General Gastro News Articles

Gastro

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nguyen MH et al. – No rtM204V/I or rtN236T mutations were observed in study. Less than 1% of patients had mutations that can be associated with primary resistance to existing anti–viral therapies for hepatitis B virus.

Related Articles

Hepatitis B does not increase risk for pancreatic cancer
EurekAlert, 11/02/09    Relevance Score: 70%

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09    Relevance Score: 70%

Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09    Relevance Score: 69%

Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09    Relevance Score: 69%

Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09    Relevance Score: 69%

Today in Hepatology...keeping you current

Liver functional reserve estimation: state of the art and relevance for local treatments
Journal of Hepato-Biliary-Pancreatic Surgery, 11/23/09

Surgical technique: new advances for expanding indications and increasing safety in liver resection for HCC
Journal of Hepato-Biliary-Pancreatic Surgery, 11/23/09

Noninvasive Positive Pressure Ventilation to Prevent Respiratory Collapse after Extubation: Clinical Case Reports
Transplantation Proceedings, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address